Anton Gueth, Director at ANTARES PHARMA, INC. (ATRS), bought 50,000 shares at $0.72 ($36K) on 2016-03-18, disclosed to the SEC on 2016-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATRS | SELL | 2013-09-05 | $111K | — | Filing → |
| ATRS | SELL | 2013-08-05 | $110K | — | Filing → |
| ATRS | SELL | 2013-07-03 | $104K | — | Filing → |